Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M749Revenue $M158Net Margin (%)-24.9Z-Score1.9
Enterprise Value $M592EPS $-1.4Operating Margin %-16.9F-Score6
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-24.3Higher ROA y-yY
Price/Book4.610-y EBITDA Growth Rate %0Quick Ratio10.0Cash flow > EarningsY
Price/Sales4.95-y EBITDA Growth Rate %-19.1Current Ratio10.2Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-15.9Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-30.3Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M28.4ROI % (ttm)-14.4Gross Margin Increase y-yY

Gurus Latest Trades with AEGR

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AEGRMichael Price 2014-12-31 Sold Out -1%$19.66 - $35.02
($25.02)
$ 26.255%Sold Out0
AEGRGeorge Soros 2014-12-31 Sold Out -0.01%$19.66 - $35.02
($25.02)
$ 26.255%Sold Out0
AEGRJoel Greenblatt 2014-12-31 Sold Out $19.66 - $35.02
($25.02)
$ 26.255%Sold Out0
AEGRGeorge Soros 2014-09-30 Buy 0.01%$26.93 - $35.65
($30.96)
$ 26.25-18%New holding25,000
AEGRJoel Greenblatt 2014-09-30 Buy $26.93 - $35.65
($30.96)
$ 26.25-18%New holding10,964
AEGRMichael Price 2014-03-31 Buy 1.1%$43.65 - $73.75
($59.26)
$ 26.25-126%New holding200,000
AEGRAndreas Halvorsen 2014-03-31 Sold Out -0.29%$43.65 - $73.75
($59.26)
$ 26.25-126%Sold Out0
AEGRAndreas Halvorsen 2013-09-30 Add0.33%$68.93 - $96.93
($85)
$ 26.25-224%Add 1969.20%744,788
AEGRAndreas Halvorsen 2013-06-30 Buy 0.01%$37.66 - $74.95
($53.09)
$ 26.25-102%New holding35,994
AEGRGeorge Soros 2012-06-30 Sold Out -0.01%$11.76 - $16.96
($14.02)
$ 26.2547%Sold Out0
AEGRGeorge Soros 2011-06-30 Buy 0.01%$15.29 - $21.85
($17.62)
$ 26.2533%New holding37,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AEGR is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


AEGR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Fitzpatrick Mark J.CFO 2014-08-19Buy1,150$30.64-17.27view
Beer Marc DCEO 2014-07-31Buy10,000$33.65-24.67view
Beer Marc DCEO 2014-06-03Buy10,000$30.12-15.84view
Beer Marc DCEO 2014-05-27Buy10,000$31.59-19.75view
Beer Marc DCEO 2014-05-20Buy10,000$30.53-16.97view
Beer Marc DCEO 2014-05-08Buy30,000$35.31-28.21view
VANLENT ANNEDirector 2014-05-08Buy4,000$33.78-24.96view
Fraser CraigPres., US/Int. Comm. & Manuf. 2014-04-30Sell2,250$43.55-41.79view
Fraser CraigPres., US/Int. Comm. & Manuf. 2014-03-31Sell2,250$46.2-45.13view
Sumeray MarkChief Medical Officer 2014-03-14Sell2,000$51.34-50.62view

Press Releases about AEGR :

    Quarterly/Annual Reports about AEGR:

      News about AEGR:

      Articles On GuruFocus.com
      Gilead Sciences Releases Impressive Results for Hepatitis C Drug Nov 12 2014 
      Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 
      Weekly CEO Buys Highlight: GEO, TRUE, BANC, AEGR, CLMS Jun 02 2014 
      Three CEOs Reporting Large Insider Buys May 22 2014 
      Four CEOs Reporting Large Insider Buys May 09 2014 
      100 Stocks at All-Time Highs | 60 Dividend Stocks Below the Results Feb 19 2013 
      My 3 Favorite Dividend Stocks at All-Time-Highs | Stock List Dec 27 2012 
      Weekly CFO Buys Highlight: RXN, XBKS, STAG, AEGR, PZG Apr 02 2012 

      More From Other Websites
      AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K/A, Completion of Acquisition or Disposition of... Mar 25 2015
      Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program Mar 10 2015
      Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program Mar 10 2015
      AEGERION PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report Mar 02 2015
      Aegerion Pharmaceuticals Observes Rare Disease Day Feb 28 2015
      Aegerion Pharmaceuticals Observes Rare Disease Day Feb 28 2015
      Aegerion's Q4 Loss Narrows Y/Y, Ups Juxtapid Sales View - Analyst Blog Feb 27 2015
      Aegerion reports 4Q loss Feb 26 2015
      Aegerion reports 4Q loss Feb 26 2015
      Aegerion Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today Feb 26 2015
      Aegerion Pharmaceuticals Announces Fourth Quarter and Full Year 2014 Financial Results Feb 26 2015
      Aegerion Pharmaceuticals Announces Fourth Quarter and Full Year 2014 Financial Results Feb 26 2015
      Q4 2014 Aegerion Pharmaceuticals Inc Earnings Release - After Market Close Feb 26 2015
      Aegerion Pharmaceuticals Announces Presentation at the Cowen and Company Healthcare Conference Feb 25 2015
      Aegerion Pharmaceuticals Announces Presentation at the Cowen and Company Healthcare Conference Feb 25 2015
      Will Aegerion (AEGR) Miss Earnings Estimates This Season? - Analyst Blog Feb 24 2015
      Activists want 'imminent retirement' of Ariad CEO Feb 20 2015
      Aegerion Pharmaceuticals to Announce Fourth-Quarter and Full-Year 2014 Financial Results on... Feb 12 2015
      Aegerion Pharmaceuticals to Announce Fourth-Quarter and Full-Year 2014 Financial Results on... Feb 12 2015
      Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program Feb 10 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK